The Sackler Jews—responsible for the Opioid addiction crisis which has killed over half a million people in America—have been forced to pay out $275 million in a “settlement” in the third of 1,600 lawsuits against them.
The agreement, negotiated with the state of Oklahoma, will allow the Sackler company, Purdue Pharmacy, which makes OxyContin, to avoid a televised courtroom trial.
The payment is the third “settlement” that Purdue Pharma has reached in the 1,600 cases against it, and has obviously chosen to pay out rather than face the already-in-place plans for a televised trial and resultant publicity—and the possibility of a massive jury-inflicted payout order.
According to the New York Times, the number of cases lined up against Purdue is potentially so damaging that the company has started exploring the possibility of filing for Chapter 11 bankruptcy restructuring, which will temporarily insulate it from big judgments.
There are still 35 other state cases pending against Purdue, as well as in the federal litigation, which combines 1600 suits brought by cities, counties, American Indian tribes, and others.
A statement issued by Oklahoma Attorney General Mike Hunter said that the payout will be used to “establish a nearly $200 million endowment at the Oklahoma State University’s Center for Wellness and Recovery, which will go toward treating the ongoing addiction epidemic nationwide.”
Beginning January 1, 2020, the entity will receive an annual $15 million payment over a five year period. During the same five year timeframe, it will receive ongoing contributions of addiction treatment medicine, valued at $20 million.
“The addiction crisis facing our state and nation is a clear and present danger,” Attorney General Hunter said. “Last year alone, out of the more than 3,000 Oklahomans admitted to the hospital for a non-fatal overdose, 80 percent involved a prescription opioid medication. Additionally, nearly 50 percent of Oklahomans who died from a drug overdose in 2018 were attributed to a pharmaceutical drug. Deploying the money from this settlement immediately allows us to decisively treat addiction illness and save lives.”
In addition, he said, $12.5 million will go towards providing funds to directly abate and address the opioid epidemic’s effects in Oklahoma’s cities and counties. Purdue will also make a $60 million payment to offset all litigation costs up to this point, and has agreed not to continue promoting opioids in Oklahoma, including employing or contracting with sales representatives to health care providers.
The opioid plague which has killed nearly half a million people in America since the year 2000—of which at least 450,000 were whites, according to statistics kept by the Henry J Kaiser Family Foundation, which draws data provided by the US Government’s Centers for Disease Control (CDC).
The Sackler Trust, which is a major donor to museums in America and Britain, is also finding itself under siege as awareness of the extent of their opioid genocide becomes more widespread.
First announced in 2016, the Sackler Trust’s planned gift was meant to support the National Portrait Gallery’s Inspiring People project, which the museum is touting as its largest development project in over a century. The project, which is expected to cost an estimated £35.5 million ($46.5 million), allows for a new entrance, a new learning center, and a redisplay of the collection, among other facets.
The Tate, a collection of four art museums housing the UK’s national collection of British art, and international modern and contemporary art, whose main sponsor is the British government’s Department for Digital, Culture, Media and Sport, has also announced that it will no longer accept donations from the Sacklers.
Previous donations from the Sackler Trust have been used to build the famous “Sackler Octagon” in the Tate, a reception room for up to 300 guests.
A Tate spokesperson told the Telegraph newspaper that the “Sackler family has given generously to Tate in the past, as they have to a large number of UK arts institutions. We do not intend to remove references to this historic philanthropy. However, in the present circumstances we do not think it right to seek or accept further donations from the Sacklers.”
Dame Theresa Sackler is chair of the Sackler Trust, a board member of the Victoria and Albert Museum and a trustee of the Tate Foundation. She is facing civil charges in the US due to her involvement with Purdue Pharma.
Tthe Guggenheim Museum in New York also said it would decline Sackler funding in the future.